1-15 of 15
Bo Ahren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

746-P: Semaglutide Increases the Proportion of People with T2D Achieving a Metabolic Composite Endpoint

LINONG JI, ANDREW AHMANN, BO AHRÉN, MATTHEW CAPEHORN, PING HU, ILDIKO LINGVAY, WENYAN LIU, HELENA W. RODBARD, ZEWEI SHEN, CHRISTOPHER H. SORLI
Journal: Diabetes
Diabetes 2023;72(Supplement_1):746-P
https://doi.org/10.2337/db23-746-P
Published: 20 June 2023
View article titled, 746-P: Semaglutide Increases the Proportion of People with T2D Achieving a Metabolic Composite Endpoint
Meeting Abstracts

549-P: A Premeal Drink of Low-Dose Whey Protein (WP) Microgel Rapidly Increases Bioavailability of Branched Chain Amino Acids (BCAA) in People with Type 2 Diabetes (T2D) : A Randomized, Placebo-Controlled Crossover Study

IAN NEELAND, BO AHRÉN, JOHN V. CORTHÉSY, YOHAN GRZYWINSKI, ZOLTAN MAGOS, MAXIMILIAN VON EYNATTEN, ODD ERIK JOHANSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):549-P
https://doi.org/10.2337/db22-549-P
Published: 01 June 2022
View article titled, 549-P: A Premeal Drink of Low-Dose Whey Protein (WP) Microgel Rapidly Increases Bioavailability of Branched Chain Amino Acids (BCAA) in People with Type 2 Diabetes (T2D) : A Randomized, Placebo-Controlled Crossover Study
Meeting Abstracts

37-LB: Very-Low-Dose Premeal Whey Protein Microgels Reduce Postprandial (PP) Glucose in Type 2 Diabetes: A Randomized, Placebo-Controlled Crossover Study

LUIZ H. DE GREGORIO, IAN NEELAND, ROBERTO ZAGURY, BO AHRÉN, JOEL M. NEUTEL, KEMUEL REYES, EMILIE PERRIN, EVAN BERK, MAXIMILIAN VON EYNATTEN, ODD ERIK E. JOHANSEN
Journal: Diabetes
Diabetes 2021;70(Supplement_1):37-LB
https://doi.org/10.2337/db21-37-LB
Published: 01 June 2021
View article titled, 37-LB: Very-Low-Dose Premeal Whey Protein Microgels Reduce Postprandial (PP) Glucose in Type 2 Diabetes: A Randomized, Placebo-Controlled Crossover Study
Journal Articles

Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

Kristine Færch, Dorte Vistisen, Giovanni Pacini, Signe S. Torekov, Nanna B. Johansen, Daniel R. Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Marit E. Jørgensen, Bo Ahrén, Jens Juul Holst
Journal: Diabetes
Diabetes 2016;65(11):3473–3481
https://doi.org/10.2337/db16-0240
Published: 08 August 2016
View article titled, Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation
Open the PDF for Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation in another window
Journal Articles

Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes

Bo Ahrén
Journal: Diabetes
Diabetes 2015;64(3):715–717
https://doi.org/10.2337/db14-1671
Published: 17 February 2015
View article titled, Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes
Open the PDF for Hepato-Incretin Function of GLP-1: Novel Concept and Target in Type 1 Diabetes in another window
Journal Articles

Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors

Bilal Omar, Bo Ahrén
Journal: Diabetes
Diabetes 2014;63(7):2196–2202
https://doi.org/10.2337/db14-0052
Published: 14 June 2014
View article titled, Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors
Open the PDF for Pleiotropic Mechanisms for the Glucose-Lowering Action of DPP-4 Inhibitors in another window
Journal Articles

Fibroblast Growth Factor 21 (FGF21) and Glucagon-Like Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor–Deficient Mice

Bilal A. Omar, Birgitte Andersen, Jacob Hald, Kirsten Raun, Erica Nishimura, Bo Ahrén
Journal: Diabetes
Diabetes 2014;63(1):101–110
https://doi.org/10.2337/db13-0710
Published: 13 December 2013
View article titled, Fibroblast Growth Factor 21 (FGF21) and Glucagon-Like Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor–Deficient Mice
Open the PDF for Fibroblast Growth Factor 21 (FGF21) and Glucagon-Like Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor–Deficient Mice in another window
Includes: Supplementary data
Journal Articles

Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function

Heidi Sørensen, Maria Sörhede Winzell, Christian L. Brand, Keld Fosgerau, Richard W. Gelling, Erica Nishimura, Bo Ahren
Journal: Diabetes
Diabetes 2006;55(12):3463–3469
https://doi.org/10.2337/db06-0307
Published: 01 December 2006
View article titled, Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function
Open the PDF for Glucagon Receptor Knockout Mice Display Increased Insulin Sensitivity and Impaired β-Cell Function in another window
Journal Articles

In Vivo and In Vitro Glucose-Induced Biphasic Insulin Secretion in the Mouse: Pattern and Role of Cytoplasmic Ca2+ and Amplification Signals in β-Cells

Jean-Claude Henquin, Myriam Nenquin, Patrick Stiernet, Bo Ahren
Journal: Diabetes
Diabetes 2006;55(2):441–451
https://doi.org/10.2337/diabetes.55.02.06.db05-1051
Published: 01 February 2006
View article titled, In Vivo and In Vitro Glucose-Induced Biphasic Insulin Secretion in the Mouse: <subtitle>Pattern and Role of Cytoplasmic Ca<sup>2+</sup> and Amplification Signals in β-Cells</subtitle>
Open the PDF for In Vivo and In Vitro Glucose-Induced Biphasic Insulin Secretion in the Mouse: <subtitle>Pattern and Role of Cytoplasmic Ca<sup>2+</sup> and Amplification Signals in β-Cells</subtitle> in another window
Journal Articles

Aged Transgenic Mice With Increased Glucocorticoid Sensitivity in Pancreatic β-Cells Develop Diabetes

Behrous Davani, Neil Portwood, Galina Bryzgalova, Martina Kvist Reimer, Thomas Heiden, Claes-Göran Östenson, Sam Okret, Bo Ahren, Suad Efendic, Akhtar Khan
Journal: Diabetes
Diabetes 2004;53(suppl_1):S51–S59
https://doi.org/10.2337/diabetes.53.2007.S51
Published: 01 February 2004
View article titled, Aged Transgenic Mice With Increased Glucocorticoid Sensitivity in Pancreatic β-Cells Develop Diabetes
Open the PDF for Aged Transgenic Mice With Increased Glucocorticoid Sensitivity in Pancreatic β-Cells Develop Diabetes in another window
Journal Articles

Activation of Autonomic Nerves and the Adrenal Medulla Contributes to Increased Glucagon Secretion During Moderate Insulin-Induced Hypoglycemia in Women

Peter J Havel, Bo Ahren
Journal: Diabetes
Diabetes 1997;46(5):801–807
https://doi.org/10.2337/diab.46.5.801
Published: 01 May 1997
View article titled, Activation of Autonomic Nerves and the Adrenal Medulla Contributes to Increased Glucagon Secretion During Moderate Insulin-Induced Hypoglycemia in Women
Open the PDF for Activation of Autonomic Nerves and the Adrenal Medulla Contributes to Increased Glucagon Secretion During Moderate Insulin-Induced Hypoglycemia in Women in another window
Journal Articles

Plasma Leptin Levels Correlate to Islet Function Independently of Body Fat in Postmenopausal Women

Hillevi Larsson, Sö Elmståhl, Bo Ahrén
Journal: Diabetes
Diabetes 1996;45(11):1580–1584
https://doi.org/10.2337/diab.45.11.1580
Published: 01 November 1996
View article titled, Plasma Leptin Levels Correlate to Islet Function Independently of Body Fat in Postmenopausal Women
Open the PDF for Plasma Leptin Levels Correlate to Islet Function Independently of Body Fat in Postmenopausal Women in another window
Journal Articles

Dexamethasone-Induced Neuropeptide Y Expression in Rat Islet Endocrine Cells: Rapid Reversibility and Partial Prevention by Insulin

Ulrika Myrsén, Bo Ahrén, Frank Sundler
Journal: Diabetes
Diabetes 1996;45(10):1306–1316
https://doi.org/10.2337/diab.45.10.1306
Published: 01 October 1996
View article titled, Dexamethasone-Induced Neuropeptide Y Expression in Rat Islet Endocrine Cells: Rapid Reversibility and Partial Prevention by Insulin
Open the PDF for Dexamethasone-Induced Neuropeptide Y Expression in Rat Islet Endocrine Cells: Rapid Reversibility and Partial Prevention by Insulin in another window
Journal Articles

Comparison of Effects of Neuropeptide Y and Norepinephrine on Insulin Secretion and Vascular Resistance in Perfused Rat Pancreas

Gunnar Skoglund, René A Gross, Gyslaine R Bertrand, Bo Ahrén, Marie-Madeleine Loubatières-Mariani
Journal: Diabetes
Diabetes 1991;40(6):660–665
https://doi.org/10.2337/diab.40.6.660
Published: 01 June 1991
View article titled, Comparison of Effects of Neuropeptide Y and Norepinephrine on Insulin Secretion and Vascular Resistance in Perfused Rat Pancreas
Open the PDF for Comparison of Effects of Neuropeptide Y and Norepinephrine on Insulin Secretion and Vascular Resistance in Perfused Rat Pancreas in another window
Journal Articles

Pancreastatin Inhibits Insulin Secretion and Stimulates Glucagon Secretion in Mice

Bo Ahrén, Stefan Lindskog, Kazuhiko Tatemoto, Suad Efendić
Journal: Diabetes
Diabetes 1988;37(3):281–285
https://doi.org/10.2337/diab.37.3.281
Published: 01 March 1988
View article titled, Pancreastatin Inhibits Insulin Secretion and Stimulates Glucagon Secretion in Mice
Open the PDF for Pancreastatin Inhibits Insulin Secretion and Stimulates Glucagon Secretion in Mice in another window